The Grand Rapids-based medical technology firm, which trades under the ticker SI on the NYSE, intends to showcase its integrated approach to shoulder surgical care. Their current portfolio centers on advanced implant systems designed to streamline preoperative planning and procedural workflows for surgeons.

Investors and interested parties can access a live or archived version of the session through the investor relations portal on the company's website. The firm positions its technology as a solution to long-standing clinical inefficiencies, aiming to deliver predictable patient outcomes through a combination of simplified instrumentation and surgeon-to-surgeon collaborative tools.